CD44v6 Drives Tumor Aggressiveness and Chemoresistance in Bladder Cancer
Iris Lodewijk, Carolina Rubio, Pontus Eriksson, Ignacio A. Reina, Esther Montesinos, Miguel Alonso-Sánchez, Laura García-Gómez, Álvaro Martín de Bernardo, Lucía Morales, Cristian Suárez-Cabrera, Omaira Alberquilla, Rebeca Sánchez‐Domínguez, Félix Guerrero‐Ramos, Rosa García-Martin, Lucía Parrilla, , Marta Dueñas
This study identifies CD44v6 as a driver of bladder cancer aggressiveness and chemoresistance, linking its expression to poor patient outcomes and therapeutic resistance.
bioRxiv · Aug 27, 2025 · PreprintCancer Biology